Skip to main content
Donate
Login
Celebrate IASLC's 50th Anniversary
Celebrate IASLC's 50th Anniversary
History
Support The Mission
Support The Mission
Partners for Thoracic Cancer Care
Legacy Society
IASLC Global Member Survey on Inclusivity
About Us
About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Careers
Contact
Search
Donate
Login
Conferences & Webinars
Conferences & Webinars
Upcoming Conferences & Webinars
Past Conferences & Webinars
WCLC 2024
Research & Education
Research & Education
Publications, Resources & Guidelines
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Lung Cancer 360
Research Projects
Research Projects
Staging Project
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Early-Career Opportunities
News
News
ILCN
Press Releases
Lung Cancer Considered Podcast
Membership
Membership
Become a Member
Renew Your Membership
Partner Society Membership Offers
Patient Advocacy
Patient Advocacy
STARS
Advocacy Partner Spotlight
Lung Cancer Awareness Month 2023 Highlights
Foundation
Foundation
Donor Recognition
Research Grant Program
Grant Recipient Spotlights
Research Grant Recipients
Search
Fulltext search
Fulltext search
Search
Displaying 37 - 48 items out of 324 results
ILCN article
Immunotherapy, TKIs for Resectable/Resected NSCLC: Dr. Masahiro Tsuboi Provides a Comprehensive Overview of Promising Phase II Data, Phase III Status
ILCN article
First-line Sintilimab Plus Platinum-Based Chemotherapy Prolongs PFS in Advanced Nonsquamous NSCLC
ILCN article
Pembrolizumab Considered for Second Tissue-Agnostic Cancer Indication
ILCN article
Managing lung cancer in the time of COVID-19
ILCN article
Leora Horn, MD - IASLC Virtual Presidential Symposium Presentation
ILCN article
Paul Baas, MD - IASLC Virtual Presidential Symposium Presentation
ILCN article
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
ILCN article
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
ILCN article
PASSION Results Support Further Study of Camrelizumab Plus Apatinib in SCLC
ILCN article
Prior Pneumonitis as a Risk Factor for Treatment-Associated Pneumonitis With Immune Checkpoint Inhibitor Therapy
ILCN article
Single-Agent Pembrolizumab Active Against STK11- and KEAP1- Mutated NSCLC According to KEYNOTE-042 Analysis
ILCN article
Impact of COVID-19 on the Diagnostic Workup of Lung Cancer
Pagination
First
First page
‹
Previous page
1
2
3
4
5
6
7
8
9
…
›
Next page
Last
Last page